JP2015528502A5 - - Google Patents

Download PDF

Info

Publication number
JP2015528502A5
JP2015528502A5 JP2015532025A JP2015532025A JP2015528502A5 JP 2015528502 A5 JP2015528502 A5 JP 2015528502A5 JP 2015532025 A JP2015532025 A JP 2015532025A JP 2015532025 A JP2015532025 A JP 2015532025A JP 2015528502 A5 JP2015528502 A5 JP 2015528502A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
effective amount
bacterial infections
treating bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015532025A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015528502A (ja
JP6460991B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/059310 external-priority patent/WO2014043272A1/en
Publication of JP2015528502A publication Critical patent/JP2015528502A/ja
Publication of JP2015528502A5 publication Critical patent/JP2015528502A5/ja
Application granted granted Critical
Publication of JP6460991B2 publication Critical patent/JP6460991B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015532025A 2012-09-12 2013-09-11 抗菌剤として使用するための三環式ジャイレース阻害剤 Active JP6460991B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261700159P 2012-09-12 2012-09-12
US61/700,159 2012-09-12
PCT/US2013/059310 WO2014043272A1 (en) 2012-09-12 2013-09-11 Tricyclic gyrase inhibitors for use as antibacterial agents

Publications (3)

Publication Number Publication Date
JP2015528502A JP2015528502A (ja) 2015-09-28
JP2015528502A5 true JP2015528502A5 (https=) 2016-11-04
JP6460991B2 JP6460991B2 (ja) 2019-01-30

Family

ID=49226575

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015532025A Active JP6460991B2 (ja) 2012-09-12 2013-09-11 抗菌剤として使用するための三環式ジャイレース阻害剤

Country Status (7)

Country Link
US (1) US10865216B2 (https=)
EP (1) EP2895488B1 (https=)
JP (1) JP6460991B2 (https=)
CN (1) CN105189505B (https=)
AR (1) AR092538A1 (https=)
TW (1) TWI639602B (https=)
WO (1) WO2014043272A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2617339T3 (es) 2010-12-16 2017-06-16 Calchan Limited Derivados de pirrolopirimidina inhibidores de ASK1
EP2686320B1 (en) * 2011-03-15 2016-05-18 Merck Sharp & Dohme Corp. Tricyclic gyrase inhibitors
CN105899511B (zh) * 2013-09-11 2019-06-07 默沙东公司 三环促旋酶抑制剂
WO2016067009A1 (en) * 2014-10-28 2016-05-06 Redx Pharma Plc Compounds with activity against bacteria and mycobacteria
WO2017205977A1 (en) 2016-06-01 2017-12-07 Universite De Montreal Selection of human hematopoetic stem cells using epcr
CN106588731B (zh) * 2016-12-08 2018-06-29 河北桑迪亚医药技术有限责任公司 环丙基二苯基锍三氟甲磺酸盐的合成方法
CA3057431A1 (en) 2017-03-24 2018-09-27 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative
CN110475777B (zh) 2017-03-30 2022-04-15 豪夫迈·罗氏有限公司 用于治疗和预防细菌感染的新吡啶并[2,3-b]吲哚化合物
HRP20220790T1 (hr) 2017-05-04 2022-09-16 Bayer Cropscience Aktiengesellschaft Derivati 2-{[2-(feniloksimetil)piridin-5-il]oksi}etanamina i srodni spojevi kao pesticidi, primjerice namijenjeni zaštiti bilja
WO2018226976A1 (en) * 2017-06-08 2018-12-13 Kura Oncology, Inc. Methods and compositions for inhibiting the interaction of menin with mll proteins
EP3684361A4 (en) 2017-09-20 2021-09-08 Kura Oncology, Inc. SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHOD OF USING
CN112135618A (zh) 2018-02-20 2020-12-25 蒙特利尔大学 体内介导免疫应答的nk和dc细胞的扩增
WO2020064661A1 (en) * 2018-09-26 2020-04-02 F. Hoffmann-La Roche Ag Substituted pyridoindoles for the treatment and prophylaxis of bacterial infection
WO2020085504A1 (ja) 2018-10-26 2020-04-30 大鵬薬品工業株式会社 光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法
WO2020127624A1 (en) * 2018-12-20 2020-06-25 F. Hoffmann-La Roche Ag Oxopyrido[1,2-a]pyrimidine compounds for the treatment and prophylaxis of bacterial infection
WO2020225077A1 (en) * 2019-05-03 2020-11-12 Idorsia Pharmaceuticals Ltd Pyrimido[4,5-b]indol derivatives as pdhk1 inhibitors
UA129778C2 (uk) 2019-10-28 2025-07-30 Мерк Шарп Енд Доум Елелсі Низькомолекулярні інгібітори g12c-мутантного kras
EP4067343A4 (en) 2019-11-29 2024-01-03 Taiho Pharmaceutical Co., Ltd. NEW PHENOLIC COMPOUND OR SALT THEREOF
KR20220146458A (ko) 2020-01-23 2022-11-01 마이오포르테 테라퓨틱스 인코포레이티드 Pgdh 억제제 및 그의 제조 및 사용 방법
CN112552222B (zh) * 2020-12-18 2022-08-23 南通药明康德医药科技有限公司 一种2-(2-(叔-丁氧羰基)-2-氮杂螺[3.4]辛烷-5-基)乙酸的制备方法
CN112574085A (zh) * 2020-12-18 2021-03-30 南通药明康德医药科技有限公司 一种5-氨基-2-氮杂螺[3.4]辛烷-2-羧酸叔丁酯的制备方法
CN114763357B (zh) * 2021-01-15 2024-06-18 中国科学院上海药物研究所 吲哚并嘧啶三环类化合物及其制备方法和用途
CN113372352B (zh) * 2021-06-10 2022-08-26 青岛农业大学 吲哚3,4位并九元中环化合物及其制备方法
KR20250073215A (ko) * 2022-09-21 2025-05-27 브리스톨-마이어스 스큅 컴퍼니 tert-부틸 (2-아자비시클로[2.2.1]헵탄-4-일)카르바메이트 및 관련 화합물을 제조하는 방법
WO2024103010A1 (en) * 2022-11-11 2024-05-16 Merck Sharp & Dohme Llc Small molecule inhibitors of kras proteins
EP4709371A1 (en) * 2023-05-09 2026-03-18 Merck Sharp & Dohme LLC Small molecule inhibitors of kras g12d mutant
AU2024361909A1 (en) 2023-10-20 2026-03-26 Merck Sharp & Dohme Llc Small molecule inhibitors of kras proteins
WO2025240742A1 (en) * 2024-05-15 2025-11-20 Merck Sharp & Dohme Llc Protein degraders of kras g12d mutant

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN157280B (https=) 1983-07-15 1986-02-22 Hoechst India
DE4030059A1 (de) 1990-09-22 1992-03-26 Bayer Ag Verfahren zur herstellung von 5-hydroxy-3,4,5,6-tetrahydro-pyrimidin-derivaten
DE4032560A1 (de) 1990-10-13 1992-04-16 Bayer Ag 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate
US5279359A (en) 1992-06-26 1994-01-18 Erickson Donald C Rotary trisorption heat pump
US5527910A (en) 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
SK10572002A3 (sk) 2000-01-24 2003-10-07 Warner-Lambert Company 3-Aminochinazolín-2,4-diónové antibakteriálne činidlá
US20080051414A1 (en) 2003-10-14 2008-02-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
US20090099165A1 (en) 2003-10-14 2009-04-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
JP4845736B2 (ja) * 2003-10-14 2011-12-28 アリゾナ ボード オブ リージェンツ オン ビハーフ ザ ユニバーシティー オブ アリゾナ プロテインキナーゼ阻害剤
US20090143399A1 (en) 2003-10-14 2009-06-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
US7776855B2 (en) 2006-07-27 2010-08-17 Janssen Pharmaceutica N.V. Antimicrobial oxazolidinone prodrugs
US9481675B2 (en) * 2009-09-11 2016-11-01 Merck Sharp & Dohme Corp. Gyrase inhibitors
EP2686320B1 (en) * 2011-03-15 2016-05-18 Merck Sharp & Dohme Corp. Tricyclic gyrase inhibitors
CN105899511B (zh) * 2013-09-11 2019-06-07 默沙东公司 三环促旋酶抑制剂

Similar Documents

Publication Publication Date Title
JP2015528502A5 (https=)
HUE042134T2 (hu) Monobaktám szerves vegyületek bakteriális fertõzések kezelésére
JP2015503422A5 (https=)
LT3513809T (lt) Medicininė kompozicija, apimanti tivozanibą
JP2016028092A5 (https=)
EP3423037A4 (en) ORAL ADMINISTRATIVE COMPOSITION
JP2016065085A5 (https=)
LT2984166T (lt) Kompozicijos, skirtos mpsi gydymui
JP2016502162A5 (https=)
LT3251678T (lt) Benzoksaborolo dariniai, skirti bakterinių infekcijų gydymui
JP2016535100A5 (https=)
JP2014530840A5 (https=)
BR112015003259A2 (pt) composto, composição farmacêutica, e, composição de vacina.
PL3043769T3 (pl) Hipertoniczne, terapeutyczne kompozycje przeciwdrobnoustrojowe
EP3324987A4 (en) Bacteriophage for treating staphylococcus infections
LT3436074T (lt) Tiazolido junginiai, skirti virusinių infekcijų gydymui
SI2777689T1 (sl) Nov farmacevtski sestavek za zdravljenje glivičnih infekcij
LT2939665T (lt) Farmacinė kompozicija, skirta živ infekcijų gydymui
JP2015537124A5 (https=)
BR112015016033A2 (pt) composições e métodos para tratamento de infecções por bactérias
DK3273797T3 (da) Sammensætning til at inhibere gram-positive, patogene bakterier
WO2015024016A3 (en) 2-piperidinyl substituted n,3-dihydroxybutanamides
BR112014032501A2 (pt) composto, e, composição farmacêutica.
WO2016020408A3 (en) Compounds for preventing ototoxicity
PL2970244T3 (pl) Nowe związki 1,2,4-oksadiazolu aktywne względem patogenów Gram-dodatnich